Share-based Payment Arrangement, Expense of OptiNose, Inc. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
OptiNose, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • OptiNose, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $1,410,000, a 3.2% decline year-over-year.
  • OptiNose, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $6,416,000, a 25% increase year-over-year.
  • OptiNose, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6,462,000, a 24% increase from 2023.
  • OptiNose, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5,201,000, a 41% decline from 2022.
  • OptiNose, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8,877,000, a 11% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

OptiNose, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,416,000 $1,410,000 -$46,000 -3.2% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $6,462,000 $981,000 +$10,000 +1% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q3 2024 $6,452,000 $1,290,000 +$85,000 +7.1% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $6,367,000 $2,735,000 +$1,232,000 +82% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,135,000 $1,456,000 -$66,000 -4.3% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $5,201,000 $971,000 -$512,000 -35% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $5,713,000 $1,205,000 -$745,000 -38% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $6,458,000 $1,503,000 -$1,941,000 -56% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $8,399,000 $1,522,000 -$478,000 -24% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $8,877,000 $1,483,000 -$493,000 -25% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $9,370,000 $1,950,000 -$734,000 -27% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $10,104,000 $3,444,000 +$711,000 +26% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $9,393,000 $2,000,000 -$610,000 -23% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $10,003,000 $1,976,000 -$515,000 -21% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $10,518,000 $2,684,000 +$58,000 +2.2% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $10,460,000 $2,733,000 -$39,000 -1.4% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $10,499,000 $2,610,000 +$150,000 +6.1% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $10,349,000 $2,491,000 +$185,000 +8% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $10,164,000 $2,626,000 +$191,000 +7.8% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $9,973,000 $2,772,000 +$75,000 +2.8% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $9,898,000 $2,460,000 +$38,000 +1.6% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $9,860,000 $2,306,000 +$88,000 +4% 01 Oct 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q3 2019 $9,772,000 $2,435,000 +$233,000 +11% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $9,539,000 $2,697,000 +$597,000 +28% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020 2020 Q2
Q1 2019 $8,942,000 $2,422,000 +$399,000 +20% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $8,543,000 $2,218,000 -$1,078,000 -33% 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $9,621,000 $2,202,000 +$1,431,000 +186% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $8,190,000 $2,100,000 +$1,793,000 +584% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $6,397,000 $2,023,000 +$1,301,000 +180% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $5,096,000 $3,296,000 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $771,000 +$737,000 +2168% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $307,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $722,000 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q3 2016 $34,000 01 Jul 2016 30 Sep 2016 10-Q 27 Nov 2017 2017 Q3

OptiNose, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,462,000 +$1,261,000 +24% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $5,201,000 -$3,676,000 -41% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $8,877,000 -$1,126,000 -11% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $10,003,000 -$346,000 -3.3% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 $10,349,000 +$489,000 +5% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $9,860,000 +$1,317,000 +15% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
2018 $8,543,000 +$3,447,000 +68% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $5,096,000 +$4,497,000 +751% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $599,000 +$11,000 +1.9% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
2015 $588,000 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.